ROBINSON, S. Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia After BTK Inhibitor and/or BCL-2 Inhibitor Failure. Canadian Hematology Today, Toronto, Canada, v. 3, n. 2, p. 49–53, 2024. DOI: 10.58931/cht.2024.3255. Disponível em: https://canadianhematologytoday.com/article/view/3-2-robinson. Acesso em: 21 nov. 2024.